Endo International plc, a provider of generic pharmaceuticals, has introduced a generic 2% topical testosterone gel, an authorized generic of FORTESTA Gel CIII, indicated for the treatment of males with hypogonadism. FORTESTA Gel and its Authorized ... Individual.com, 1 month ago
Endo announces launch of Authorized Generic of FORTESTA® Gel - FiercePharma, 1 month ago
Endo launches Fortesta Gel authorized generic - Chain Drug Review, 1 month ago
1 images for "Qualitest Pharmaceuticals"
SPRINGFIELD, Ill. Pharmaceutical distributor H.D. Smith has announced the winners of its annual Trading Partners of the Year award. H.D. Smith said Thursday that the awards recognize pharmaceutical and health products manufacturers who collaborate ...Chain Drug Review, 1 month ago H. D. Smith announces winners of annual Trading Partners of the Year award News-Medical.Net, 1 month ago H. D. Smith Recognizes 2014 Trading Partners of the Year Tamar Securities, 1 month ago Large Volume Wearable Injectors - 2nd Edition Yahoo! Finance, 3 weeks ago
By , Executive Editor, Outsourced Pharma Follow Me On Twitter @Louis_Garguilo Peter Bigelow,President, xCell StrategicConsulting , would be forgiven if he were not excited about another conference and exhibition. He's been attending these ...Pharmaceutical Online, 2 months ago
Trxade Group, Inc. (TRXD: OTCQB) | Trxade Group, Inc. Advances to Direct Sales Model Utilizing Existing Pharmaceutical Network
- Tr x ade Group, Inc. ( OTCQB : TRXD ), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced the launch of our new direct sales model ...Pink Sheets, 2 weeks ago Trxade Group, Inc. Advances to Direct Sales Model Utilizing Existing Pharmaceutical Network Scottrade, 2 weeks ago Trxade : Advances to Direct Sales Model Utilizing Existing Pharmaceutical Network 4 Traders, 2 weeks ago
By The Food and Drug Administration (FDA) has released its Drug product Enforcement Report for October 1, 2014. The agency publicizes recalls in its weekly report as press releases are not issued for all recalls. Manufacturers issue recalls ...Pharmaceutical Online, 1 week ago
Summary Endo publicly announces its desire to acquire Auxilium for $28.10 per share. Auxilium is currently playing it cool, but Endo's deal offers credible sales synergy, a chance to maximize the value of Xiaflex, and good cost and tax leverage ...Seeking Alpha, 1 month ago
Xiaflex by Auxilium Four Am Law 100 firms are facing off in a takeover fight involving Endo International's unsolicited $2.2 billion cash-and-stock bid to buy Auxilium Pharmaceuticals. The proposed transaction would scuttle Auxilium's ...American Lawyer.com, 1 month ago
NAXS Nordic Access Buyout Fund : New exit: Funds advised by Apax Partners divest TriZetto Corporation
Denver, Colorado and London, UK- Funds advised by Apax Partners ("Apax") today announced that they have agreed to sell their majority ownership stake in the TriZetto Corporation ("TriZetto"). TriZetto, a provider of world-class healthcare ...4 Traders, 1 month ago Funds advised by Apax Partners agree to sell their majority stake in the TriZetto Corporation to Cognizant Technology Solutions Stockwatch, 1 month ago New exit: Funds advised by Apax Partners divest TriZetto Corporation Noodls, 1 month ago Cognizant Technology Solutions : Funds advised by Apax Partners agree to sell their majority stake in the TriZetto Corporation to Cognizant Technology Solutions 4 Traders, 1 month ago
, Aurobindo 125 mg, 100 count bottle (NDC 65862-0401-01) - discontinued 125 mg, 500 count bottle (NDC 65862-0401-05) - discontinued 250 mg, 100 count bottle (NDC 65862-0402-01) - discontinued 250 mg, 500 count bottle (NDC 65862-0402-05) - ...ASHP, 1 month ago
on your WebpageAdd Widget >Get your members hooked!